Hormone replacement therapy in menopause as a risk factor for developing breast cancer

with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol

Para concluir esta especialidade e com grau de mestre tenho que efectuar um trabalho de investigação.Esse trabalho irá abordar a sintomatologia depressiva e o estado

for repeated injections which could cause inflammation of the breast tissue and in- crease in the risk for cancer and develop- ment of nodules; alterations in the breast anatomy

If Kardec defined spiritism as the science which investigates the nature, origin, and destiny of the spirits and their relation with man, conceding to it a scientific,

Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2- positive

Considering the specifics of the use case, the ISO/TC211 Land Administration Domain Model (LADM, DIS 19152) is used as a basis for the development of a specialized profile addressing

The debate over the use of hormone therapy in meno- pause is old, from the 1963 feminist movement “Feminine Forever” to the first reports of cases of endometrial and breast

Adjuvant hormone therapy with tamoxifen was re- sponsible for a reduction in the risk of recurrence of 41% and in the risk of death from breast cancer of 34% in wom- en in a study